Clinical Trials Browser

Phase 2 × Advanced Breast Cancer × Trastuzumab × Clear all

NCT03931551 2023-02-22

OPHELIA

Phase 2 Terminated

Advanced Breast Cancer

NCT05020964 2021-08-25

Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib

Phase 2 Unknown

Advanced Breast Cancer